Revelations in Retinal Vein Occlusion Management – What’s New?

0.75 CME
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Faculty Photo


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Activity Description

Retinal vein occlusions (RVOs) are the second leading cause of vision loss due to retinal vascular disease. New imaging technologies and potential biomarkers, along with the refinement of current diagnostic tools, are aiding in early and accurate diagnosis of RVO, allowing for timely initiation and monitoring of therapy. Therapeutic options for patients with RVO have also evolved, with clinical studies demonstrating that in patients with central or branch RVO-related macular edema, significant visual and anatomic improvements were reported in patients receiving intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors. In this continuing medical education activity, experts in the field examine how innovations in imaging can improve the management of RVO and discuss how advances in the treatment of RVO achieved in clinical studies can be applied to real-world practice.

Target Audience

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinal vein occlusion (RVO).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Examine innovations in imaging that can improve the overall management of RVO.
  • Examine how advances in the treatment of RVO achieved in clinical trials can be applied to real-world practice.

Activity Chair

Rishi P. Singh, MD
Staff Physician
Center for Ophthalmic Bioinformatics
Cole Eye Institute
Cleveland Clinic Foundation
Professor of Ophthalmology
Lerner College of Medicine
Case Western Reserve University
Cleveland, OH


Michael S. Ip, MD
Professor of Ophthalmology
Medical Director, Doheny Image Reading Center
Doheny Eye Institute
University of California – Los Angeles
Pasadena, CA

Yasha Modi, MD
Associate Professor of Ophthalmology
New York University
New York, NY


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn credits equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, June 30, 2021, to June 29, 2022.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Activity Chair and Faculty report the following relationship(s)

Rishi P. Singh, MD
Consulting Fee: Alcon, Apellis, Genentech, Gyroscope, Novartis, Regeneron, Zeiss
Contracted Research: Aerie, Apellis, Graybug Vision

Michael S. Ip, MD
Consulting Fee: Aerie, Alimera, Allergan, Amgen, Apellis, Clearside, Genentech, Lineage Cell Therapeutics, Novartis, OccuRx, Regeneron, Regenxbio

Yasha Modi, MD
Consulting Fee: Alimera, Allergan, Genentech, Novartis, Théa, Zeiss

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at